Author:
Garrino M. -G.,Schmeer W.,Nenquin M.,Meissner H. P.,Henquin J. C.
Publisher
Springer Science and Business Media LLC
Subject
Endocrinology, Diabetes and Metabolism,Internal Medicine
Reference36 articles.
1. Gylfe E, Hellman B, Sehlin J, Täljedal I-B (1984) Interaction of sulfonylurea with the pancreatic B-cell. Experientia 40: 1126–1134
2. Geisen K, Hübner M, Hitzel V, Hrstka VE, Pfaff W, Bosies E, Regitz G, Kühnle HF, Schmidt FH, Weyer R (1978) Acylaminoalkyl-substituierte Benzoe- und Phenylalkansäuren mit blutglukose- senkender Wirkung. Arzneimittelforsch 28: 1081–1083
3. Ribes G, Trimble ER, Blayac JP, Wollheim CB, Puech R, Louba-tières-Mariani MM (1981) Effect of a new hypoglycaemic agent (HB 699) on the in vivo secretion of pancreatic hormones in the dog. Diabetologia 20: 501–505
4. Blayac JP, Loubatières-Mariani MM, Ribes G (1979) Effets in vitro d'un dérivé acyl-amino-alkyl de l'acide benzoïque: le HB 699, sur la sécrétion d'insuline et de glucagon. J Pharmacol (Paris) 10: 229–238
5. Efendic S, Enzmann F, Gutniak M, Nylen A, Zoltobrocki M (1981) Insulin, glucagon and somatostatin in the perfused rat pancreas and the effects of HB 699 (4-(2-(5 chloro-2 methoxy-benzamido)-ethyl)-benzoic acid). Acta Endocrinol 98: 573–579
Cited by
52 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献